{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:28:49Z","timestamp":1771266529397,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-024-03563-x","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T01:58:15Z","timestamp":1734314295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The importance of microvascular invasion in patients with non-functioning pancreatic neuroendocrine neoplasm"],"prefix":"10.1007","volume":"410","author":[{"given":"Wataru","family":"Izumo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shiihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehisa","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"3563_CR1","first-page":"426","volume":"1","author":"S Oberndorfer","year":"1907","unstructured":"Oberndorfer S (1907) Karzinoide Tumoren Des dunndarms. Frankf Zschr Path 1:426","journal-title":"Frankf Zschr Path"},{"key":"3563_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3:1335\u20131342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"3563_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","volume":"50","author":"T Ito","year":"2015","unstructured":"Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Takano K, Komoto I, Tanaka M, Imamura M, Jensen RT, Takayanagi R, Shimatsu A (2015) Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50:58\u201364. https:\/\/doi.org\/10.1007\/s00535-014-0934-2","journal-title":"J Gastroenterol"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s10147-022-02130-y","volume":"27","author":"T Masui","year":"2022","unstructured":"Masui T, Ito T, Komoto I, Kojima S, Kasai Y, Tanabe M, Hara K, Hirano S, Okusaka T, Ichikawa Y, Kinugasa Y, Kokudo N, Kudo A, Sakurai A, Sugihara K, Date H, Haruma K, Hijioka S, Hirata K, Yamano H, Sakamine M, Kikuchi T, Fukushima M, Imamura M, Uemoto S (2022) Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Int J Clin Oncol 27:840\u2013849. https:\/\/doi.org\/10.1007\/s10147-022-02130-y","journal-title":"Int J Clin Oncol"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063\u20133072. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol"},{"key":"3563_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/cncr.24065","volume":"115","author":"JS Hill","year":"2009","unstructured":"Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 115:741\u2013751. https:\/\/doi.org\/10.1002\/cncr.24065","journal-title":"Cancer"},{"key":"3563_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/jhbp.224","volume":"22","author":"R Doi","year":"2015","unstructured":"Doi R (2015) Determinants of surgical resection for pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci 22:610\u2013617. https:\/\/doi.org\/10.1002\/jhbp.224","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3563_CR8","unstructured":"National Comprehensive Cancer Network clinical practice guidelines in oncology (2023) Neuroendocrine Tumors Version 1. https:\/\/www.nccn.org\/login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf"},{"key":"3563_CR9","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/jne.13343","volume":"35","author":"B Kos-Kud\u0142a","year":"2023","unstructured":"Kos-Kud\u0142a B, Casta\u00f1o JP, Denecke T, Grande E, Kjaer A, Koumarianou A, de Mestier L, Partelli S, Perren A, St\u00e4ttner S, Valle JW, Fazio N (2023) European neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol 35:e13343. https:\/\/doi.org\/10.1111\/jne.13343","journal-title":"J Neuroendocrinol"},{"key":"3563_CR10","volume-title":"Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN)","author":"Japan Neuroendocrine Tumor Society","year":"2019","unstructured":"Japan Neuroendocrine Tumor Society (2019) Committee for guidelines for the diagnosis of pancreatic and gastrointestinal neuroendocrine tumors. Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). Kanehara Publishing Co. Ltd, Tokyo"},{"key":"3563_CR11","volume-title":"J. WHO classification of tumors of endocrine organs","author":"RV Lloyd","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai (2017) J. WHO classification of tumors of endocrine organs. IARC, Geneva"},{"key":"3563_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/jnci\/djs208","volume":"104","author":"G Rindi","year":"2012","unstructured":"Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104:764\u2013777. https:\/\/doi.org\/10.1093\/jnci\/djs208","journal-title":"J Natl Cancer Inst"},{"key":"3563_CR13","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/bjs.9603","volume":"101","author":"L Fischer","year":"2014","unstructured":"Fischer L, Bergmann F, Schimmack S, Hinz U, Prie\u00df S, M\u00fcller-Stich BP, Werner J, Hackert T, B\u00fcchler MW (2014) Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 101:1405\u20131412. https:\/\/doi.org\/10.1002\/bjs.9603","journal-title":"Br J Surg"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/ans.12738","volume":"86","author":"KB Song","year":"2016","unstructured":"Song KB, Kim SC, Kim JH, Hong SM, Park KM, Hwang DW, Lee JH, Lee YJ (2016) Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours. ANZ J Surg 86:563\u2013567. https:\/\/doi.org\/10.1111\/ans.12738","journal-title":"ANZ J Surg"},{"key":"3563_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000504410","volume":"60","author":"W Izumo","year":"2019","unstructured":"Izumo W, Higuchi R, Furukawa T, Yazawa T, Uemura S, Shiihara M, Yamamoto M (2019) Evaluation of the site and frequency of Lymph Node Metastasis with Non-functioning pancreatic neuroendocrine tumor. Eur Surg Res 60:219\u2013228. https:\/\/doi.org\/10.1159\/000504410","journal-title":"Eur Surg Res"},{"key":"3563_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.pan.2019.08.003","volume":"19","author":"N Harimoto","year":"2019","unstructured":"Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K (2019) Prognostic significance of neutrophil\u2013lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages. Pancreatology 19:897\u2013902. https:\/\/doi.org\/10.1016\/j.pan.2019.08.003","journal-title":"Pancreatology"},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12893-021-01178-3","volume":"21","author":"T Miura","year":"2021","unstructured":"Miura T, Ohtsuka H, Aoki T, Aoki S, Hata T, Takadate T, Maeda S, Ariake K, Kawaguchi K, Masuda K, Ishida M, Mizuma M, Nakagawa K, Morikawa T, Fujishima F, Kamei T, Sasano H, Unno M (2021) Increased neutrophil-lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification. BMC Surg 21:176. https:\/\/doi.org\/10.1186\/s12893-021-01178-3","journal-title":"BMC Surg"},{"key":"3563_CR18","volume-title":"Guidelines for diagnosis and treatment of Carcinoma of the Esophagus","author":"The Japan Esophageal Society","year":"2022","unstructured":"The Japan Esophageal Society (2022) Guidelines for diagnosis and treatment of Carcinoma of the Esophagus. Kanehara Publishing Co. Ltd, Tokyo"},{"key":"3563_CR19","volume-title":"JSCCR guidelines 2022 for the treatment of Colorectal Cancer","author":"Japanese Society for Cancer of the Colon and Rectum","year":"2022","unstructured":"Japanese Society for Cancer of the Colon and Rectum (2022) JSCCR guidelines 2022 for the treatment of Colorectal Cancer. Kanehara Publishing Co. Ltd, Tokyo"},{"key":"3563_CR20","volume-title":"Gastric Cancer Treatment guidelines","author":"Japanese Gastric Cancer Association","year":"2021","unstructured":"Japanese Gastric Cancer Association (2021) Gastric Cancer Treatment guidelines, 6th edn. Kanehara Publishing Co. Ltd, Tokyo","edition":"6"},{"key":"3563_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s11605-013-2249-7","volume":"17","author":"X Zhou","year":"2013","unstructured":"Zhou X, Xie H, Xie L, Li J, Fu W (2013) Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis. J Gastrointest Surg 17:1689\u20131697. https:\/\/doi.org\/10.1007\/s11605-013-2249-7","journal-title":"J Gastrointest Surg"},{"key":"3563_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/SLA.0000000000002123","volume":"267","author":"CG Gen\u00e7","year":"2018","unstructured":"Gen\u00e7 CG, Jilesen AP, Partelli S, Falconi M, Muffatti F, van Kemenade FJ, van Eeden S, Verheij J, van Dieren S, van Eijck CHJ, van Nieveen EJM (2018) A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors. Ann Surg 267:1148\u20131154. https:\/\/doi.org\/10.1097\/SLA.0000000000002123","journal-title":"Ann Surg"},{"key":"3563_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00428-018-2353-x","volume":"472","author":"JY Kim","year":"2018","unstructured":"Kim JY, Lee SH, An S, Kim SJ, Sung YN, Song KB, Hwang DW, Kim SC, Hong SM (2018) Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival. Virchows Arch 472:739\u2013748. https:\/\/doi.org\/10.1007\/s00428-018-2353-x","journal-title":"Virchows Arch"},{"key":"3563_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1245\/s10434-017-6260-1","volume":"25","author":"T Masui","year":"2018","unstructured":"Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, Nagai K, Kawaguchi Y, Takaori K, Uemoto S (2018) Comparison of recurrence between pancreatic and duodenal neuroendocrine neoplasms after curative resection: a single-Institution analysis. Ann Surg Oncol 25:528\u2013534. https:\/\/doi.org\/10.1245\/s10434-017-6260-1","journal-title":"Ann Surg Oncol"},{"key":"3563_CR25","volume-title":"General rules for the study of pancreatic Cancer. The 8th Edition","author":"Japan Pancreatic Society","year":"2023","unstructured":"Japan Pancreatic Society (2023) General rules for the study of pancreatic Cancer. The 8th Edition. Kanehara Publishing Co. Ltd, Tokyo"},{"key":"3563_CR26","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2016) TNM Classification of Malignant Tumours, 8th Edition. John Wiley & Sons","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"3563_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"3563_CR28","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1111\/ans.17055","volume":"91","author":"S Ha","year":"2021","unstructured":"Ha S, Song KB, Hong S, Shin D, Park Y, Kwon J, Lee W, Jun E, Lee JH, Hwang DW, Kim SC (2021) The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors. ANZ J Surg 91:E484\u2013E492. https:\/\/doi.org\/10.1111\/ans.17055","journal-title":"ANZ J Surg"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40618-021-01705-2","volume":"45","author":"V Andreasi","year":"2022","unstructured":"Andreasi V, Ricci C, Partelli S, Guarneri G, Ingaldi C, Muffatti F, Crippa S, Casadei R, Falconi M (2022) Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis. J Endocrinol Invest 45:705\u2013718. https:\/\/doi.org\/10.1007\/s40618-021-01705-2","journal-title":"J Endocrinol Invest"},{"key":"3563_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000518757","volume":"112","author":"CM Heidsma","year":"2022","unstructured":"Heidsma CM, van Roessel S, van Dieren S, Engelsman AF, Strobel O, Buechler MW, Schimmack S, Perinel J, Adham M, Deshpande V, Kjaer J, Norlen O, Gill AJ, Samra JS, Mittal A, Hoogwater FJH, Primavesi F, St\u00e4ttner S, Besselink MG, van Eijck CHJ, van Nieveen EJM (2022) International Validation of a Nomogram to predict recurrence after resection of Grade 1 and 2 nonfunctioning pancreatic neuroendocrine tumors. Neuroendocrinology 112:571\u2013579. https:\/\/doi.org\/10.1159\/000518757","journal-title":"Neuroendocrinology"},{"key":"3563_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJM199202203260804","volume":"326","author":"CG Moertel","year":"1992","unstructured":"Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D (1992) Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 326:519\u2013523. https:\/\/doi.org\/10.1056\/NEJM199202203260804","journal-title":"N Engl J Med"},{"key":"3563_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, H\u00f6rsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P (2011) Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364:501\u2013513. https:\/\/doi.org\/10.1056\/NEJMoa1003825","journal-title":"N Engl J Med"},{"key":"3563_CR33","doi-asserted-by":"publisher","unstructured":"Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, \u00d6berg K RAD001 in Advanced Neuroendocrine tumors, third trial (RADIANT-3) Study Group (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364: 514\u2013523. https:\/\/doi.org\/10.1056\/NEJMoa1009290","DOI":"10.1056\/NEJMoa1009290"},{"key":"3563_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB, Phan AT, Raderer M, Sedl\u00e1\u010dkov\u00e1 E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P, CLARINET Investigators (2014) Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 371:224\u2013233. https:\/\/doi.org\/10.1056\/NEJMoa1316158","journal-title":"N Engl J Med"},{"key":"3563_CR35","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S1470-204500572-6","volume":"22","author":"JR Strosberg","year":"2021","unstructured":"Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP, NETTER-1 investigators (2021) ) 177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol 22:1752\u20131763. https:\/\/doi.org\/10.1016\/S1470-204500572-6","journal-title":"Lancet Oncol"},{"key":"3563_CR36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/MPA.0000000000001597","volume":"49","author":"TR Halfdanarson","year":"2020","unstructured":"Halfdanarson TR, Strosberg JR, Tang L, Bellizzi AM, Bergsland EK, O\u2019Dorisio TM, Halperin DM, Fishbein L, Eads J, Hope TA, Singh S, Salem R, Metz DC, Naraev BG, Reidy-Lagunes DL, Howe JR, Pommier RF, Menda Y, Chan JA (2020) The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of pancreatic neuroendocrine tumors. Pancreas 49:863\u2013881. https:\/\/doi.org\/10.1097\/MPA.0000000000001597","journal-title":"Pancreas"},{"key":"3563_CR37","volume-title":"Clinical practice guidelines for pancreatic Cancer","author":"Japan Pancreas Society","year":"2022","unstructured":"Japan Pancreas Society (2022) Clinical practice guidelines for pancreatic Cancer. Kanehara Publishing Co. Ltd, Tokyo"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-024-03563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-024-03563-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-024-03563-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:08:38Z","timestamp":1739358518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-024-03563-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1007\/s00423-024-03563-x","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was supported by the JSPS KAKENHI under grant number 22K08858. The funders had no role in the study design, data collection, analysis, and interpretation, report writing, and the decision to submit the article for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of funding"}},{"value":"None of the authors have any financial and personal relationships with other people or organizations that could potentially and inappropriately influence (bias) our work and conclusions.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of statement"}},{"value":"This study was approved by the institutional review board of Tokyo Women\u2019s Medical University (approval number: 3954). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"8"}}